Why Ocugen Stock Is Falling Today
Shares of Ocugen (NASDAQ: OCGN) are giving up ground in Wednesday's trading. The biotech stock was down roughly 12% in the daily session as of 11 a.m. EDT.
The World Health Organization (WHO) granted Emergency Use Listing (EUL) for Bharat Biotech and Ocugen's Covaxin COVID-19 vaccine today -- a development that had been viewed as a potentially major bullish catalyst for Ocugen stock. However, the company's valuation had already posted huge gains in the lead-up to the announcement, and it looks like this is a case of investors "selling the news."
Image source: Getty Images.
Source Fool.com


